Evidence map›Paper›PMID 35651957›Full record

ArticleThe Lancet regional health. Europe2022

Willingness to receive an annual COVID-19 booster vaccine in the German-speaking D-A-CH region in Europe: A cross-sectional study.

Jakob Weitzer, Brenda M Birmann, Ilja Steffelbauer, Martin Bertau, Lukas Zenk, Guido Caniglia, Manfred D Laubichler, Gerald Steiner, Eva S Schernhammer

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Evaluating the Usefulness of Population-Wide COVID-19 Testing in the Omicron Era: Insights from a German Model.Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jakob WeitzerDepartment of Epidemiology, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna 1090, Austria.
Brenda M BirmannChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA.
Ilja SteffelbauerDepartment of Knowledge and Communication Management, Faculty of Business and Globalization, University for Continuing Education Krems, Dr.-Karl-Dorrek-Straße 30, Krems an der Donau 3500, Austria.
Martin BertauInstitute of Chemical Technology, Freiberg University of Mining and Technology, Germany.
Lukas ZenkDepartment of Knowledge and Communication Management, Faculty of Business and Globalization, University for Continuing Education Krems, Dr.-Karl-Dorrek-Straße 30, Krems an der Donau 3500, Austria.
Guido CanigliaKonrad Lorenz Institute for Evolution and Cognition Research, Klosterneuburg 3400, Austria.
Manfred D LaubichlerComplexity Science Hub Vienna, Josefstädter Straße 39, Vienna 1080, Austria.
Gerald SteinerDepartment of Knowledge and Communication Management, Faculty of Business and Globalization, University for Continuing Education Krems, Dr.-Karl-Dorrek-Straße 30, Krems an der Donau 3500, Austria.
Eva S SchernhammerDepartment of Epidemiology, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, Vienna 1090, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emergence of new coronavirus variants and waning immunity may necessitate regular COVID-19 vaccine boosters, but empirical data on population willingness for regular vaccination are limited. Methods: In August 2021, we surveyed 3,067 quota-sampled German-speaking adults residing in the D-A-CH region (Germany, Austria, Switzerland). Using multivariable adjusted ordered logistic regression models we calculated odds ratios (OR) and 95% confidence intervals (95% CIs) to assess factors associated with willingness to vaccinate annually against COVID-19. Findings: Among 2,480 participants vaccinated or planning to get vaccinated, 82·4% indicated willingness to receive annual COVID-19 boosters. This willingness was higher in Austria (OR=1·47, 95% CI, 1·19-1·82; Interpretation: Targeted promotion programs informed by political and religious engagement and mitigation measure approval are needed to increase willingness to receive regular COVID-19 boosters. Funding: Medical University of Vienna, Department of Epidemiology, Danube University Krems, Department for Knowledge and Communication Management; Austrian Society of Epidemiology.

Indexed as

Booster doseBooster jabCOVID19 pandemicVaccine hesitancy

Identifiers

PMID35651957
PMCPMC9148542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.